{
  "trial_id": "NCT02251717",
  "trial_group": "chronic kidney disease",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, gender, race, body mass index (BMI), baseline HCV RNA levels, genotype of HCV, time since kidney transplant, presence of cirrhosis, baseline liver function tests (e.g., ALT, AST, bilirubin), baseline renal function tests (e.g., creatinine, eGFR), use of immunosuppressive therapy, history of previous HCV treatment, concomitant medications, baseline hemoglobin levels, baseline platelet count, baseline white blood cell count.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "gender"
        ],
        [
          "Race/Ethnicity",
          "race"
        ],
        [
          "HCV genotype",
          "genotype of HCV"
        ],
        [
          "Cirrhosis Status",
          "presence of cirrhosis"
        ],
        [
          "Years From Most Recent Kidney Transplant",
          "time since kidney transplant"
        ],
        [
          "HCV RNA",
          "baseline HCV RNA levels"
        ],
        [
          "Prior HCV Treatment Status",
          "history of previous HCV treatment"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Ethnicity (NIH/OMB)",
        "Region of Enrollment",
        "IL28b Status",
        "HCV RNA Category"
      ],
      "remaining_candidate_features": [
        "body mass index (BMI)",
        "baseline liver function tests (e.g., ALT, AST, bilirubin)",
        "baseline renal function tests (e.g., creatinine, eGFR)",
        "use of immunosuppressive therapy",
        "concomitant medications",
        "baseline hemoglobin levels",
        "baseline platelet count",
        "baseline white blood cell count."
      ]
    },
    "processed-gen-response": "Age, gender, race, body mass index (BMI), baseline HCV RNA levels, genotype of HCV, time since kidney transplant, presence of cirrhosis, baseline liver function tests (e.g., ALT, AST, bilirubin), baseline renal function tests (e.g., creatinine, eGFR), use of immunosuppressive therapy, history of previous HCV treatment, concomitant medications, baseline hemoglobin levels, baseline platelet count, baseline white blood cell count."
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Genotype of HCV, Time Since Kidney Transplant, Cirrhosis Status, Baseline HCV RNA Levels, Baseline Liver Function Tests, Use of Contraception Methods,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Race/Ethnicity",
          "Race/Ethnicity"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ],
        [
          "HCV genotype",
          "Genotype of HCV"
        ],
        [
          "Cirrhosis Status",
          "Cirrhosis Status"
        ],
        [
          "Years From Most Recent Kidney Transplant",
          "Time Since Kidney Transplant"
        ],
        [
          "HCV RNA",
          "Baseline HCV RNA Levels"
        ]
      ],
      "remaining_reference_features": [
        "Ethnicity (NIH/OMB)",
        "IL28b Status",
        "HCV RNA Category",
        "Prior HCV Treatment Status"
      ],
      "remaining_candidate_features": [
        "Baseline Liver Function Tests",
        "Use of Contraception Methods"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Race/Ethnicity, Region of Enrollment, Genotype of HCV, Time Since Kidney Transplant, Cirrhosis Status, Baseline HCV RNA Levels, Baseline Liver Function Tests, Use of Contraception Methods"
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Gender, Ethnicity (NIH/OMB), Race/Ethnicity, Customized, Region of Enrollment, Kidney Transplant Recipient, Genotype, Cirrhosis Status, HCV RNA Level, Creatinine Clearance, eGFR, Albumin, Bilirubin, ALT, AST, Hemoglobin, Platelet Count, White Blood Cell Count.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Gender"
        ],
        [
          "Ethnicity (NIH/OMB)",
          "Ethnicity (NIH/OMB)"
        ],
        [
          "Race/Ethnicity",
          "Race/Ethnicity"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ],
        [
          "HCV genotype",
          "Genotype"
        ],
        [
          "Cirrhosis Status",
          "Cirrhosis Status"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "IL28b Status",
        "Years From Most Recent Kidney Transplant",
        "HCV RNA",
        "HCV RNA Category",
        "Prior HCV Treatment Status"
      ],
      "remaining_candidate_features": [
        "Kidney Transplant Recipient",
        "HCV RNA Level",
        "Creatinine Clearance",
        "eGFR",
        "Albumin",
        "Bilirubin",
        "ALT",
        "AST",
        "Hemoglobin",
        "Platelet Count",
        "White Blood Cell Count."
      ]
    },
    "processed-gen-response": "Age, Gender, Ethnicity (NIH/OMB), Race/Ethnicity, Region of Enrollment, Kidney Transplant Recipient, Genotype, Cirrhosis Status, HCV RNA Level, Creatinine Clearance, eGFR, Albumin, Bilirubin, ALT, AST, Hemoglobin, Platelet Count, White Blood Cell Count."
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, race, ethnicity, body mass index (BMI), genotype (1 or 4), cirrhosis status, time since kidney transplant, serum creatinine, estimated glomerular filtration rate (eGFR), HCV RNA level, liver enzymes (ALT, AST), bilirubin, albumin, international normalized ratio (INR), platelet count, hemoglobin, use of immunosuppressive therapy, use of antiviral therapy, medical history (including history of malignancy, clinically significant illness), concomitant medications.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Ethnicity (NIH/OMB)",
          "ethnicity"
        ],
        [
          "Race/Ethnicity",
          "race"
        ],
        [
          "HCV genotype",
          "genotype (1 or 4)"
        ],
        [
          "Cirrhosis Status",
          "cirrhosis status"
        ],
        [
          "Years From Most Recent Kidney Transplant",
          "time since kidney transplant"
        ],
        [
          "HCV RNA",
          "HCV RNA level"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Region of Enrollment",
        "IL28b Status",
        "HCV RNA Category",
        "Prior HCV Treatment Status"
      ],
      "remaining_candidate_features": [
        "body mass index (BMI)",
        "serum creatinine",
        "estimated glomerular filtration rate (eGFR)",
        "liver enzymes (ALT, AST)",
        "bilirubin",
        "albumin",
        "international normalized ratio (INR)",
        "platelet count",
        "hemoglobin",
        "use of immunosuppressive therapy",
        "use of antiviral therapy",
        "medical history (including history of malignancy, clinically significant illness)",
        "concomitant medications"
      ]
    },
    "processed-gen-response": "Age, sex, race, ethnicity, body mass index (BMI), genotype (1 or 4), cirrhosis status, time since kidney transplant, serum creatinine, estimated glomerular filtration rate (eGFR), HCV RNA level, liver enzymes (ALT, AST), bilirubin, albumin, international normalized ratio (INR), platelet count, hemoglobin, use of immunosuppressive therapy, use of antiviral therapy, medical history (including history of malignancy, clinically significant illness), concomitant medications."
  }
}